| Gelli Pharmacy Limited |
| Registered number: |
06759931 |
| Balance Sheet |
| as at 31 March 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
1,386,403 |
|
|
1,386,545 |
|
| Current assets |
| Debtors |
4 |
|
254,579 |
|
|
301,042 |
| Cash at bank and in hand |
|
|
344,156 |
|
|
354,812 |
|
|
|
598,735 |
|
|
655,854 |
|
| Creditors: amounts falling due within one year |
5 |
|
(138,386) |
|
|
(214,842) |
|
| Net current assets |
|
|
|
460,349 |
|
|
441,012 |
|
| Total assets less current liabilities |
|
|
|
1,846,752 |
|
|
1,827,557 |
|
|
| Provisions for liabilities |
|
|
|
(154) |
|
|
(181) |
|
|
| Net assets |
|
|
|
1,846,598 |
|
|
1,827,376 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
1,846,498 |
|
|
1,827,276 |
|
| Shareholders' funds |
|
|
|
1,846,598 |
|
|
1,827,376 |
|
|
|
|
|
|
|
|
| The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
| Dr. M Ahmadi |
| Director |
| Approved by the board on 30 December 2025 |
|
| Gelli Pharmacy Limited |
| Notes to the Accounts |
| for the year ended 31 March 2025 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Investment properties |
|
Investment properties are measured at fair value by the director at each balance sheet date. Changes in fair value are included in the profit and loss account but classified as undistributable. In arriving at taxable profits/losses, adjustment is made for such changes. Investment properties are not depreciated. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
|
Pensions |
|
Contributions to defined contribution plans are expensed in the period to which they relate. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
2 |
|
7 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
Fixtures, fittings, equipment |
|
Investment property |
|
Total |
| £ |
£ |
£ |
|
Cost/revaluation |
|
At 1 April 2024 |
1,118 |
|
1,385,595 |
|
1,386,713 |
|
At 31 March 2025 |
1,118 |
|
1,385,595 |
|
1,386,713 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 April 2024 |
168 |
|
- |
|
168 |
|
Charge for the year |
142 |
|
- |
|
142 |
|
At 31 March 2025 |
310 |
|
- |
|
310 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 March 2025 |
808 |
|
1,385,595 |
|
1,386,403 |
|
At 31 March 2024 |
950 |
|
1,385,595 |
|
1,386,545 |
|
The revaluation of freehold land and buildings was provided by the director in 2011 |
|
|
| 4 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
70,307 |
|
65,892 |
|
Other debtors |
184,272 |
|
235,150 |
|
|
|
|
|
|
254,579 |
|
301,042 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade creditors |
1,924 |
|
1,647 |
|
Taxation and social security costs |
8,956 |
|
205,171 |
|
Other creditors |
127,506 |
|
8,024 |
|
|
|
|
|
|
138,386 |
|
214,842 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Transactions with the director |
|
|
The company afforded its director the use of a current account during the year. The movements on this account in summary form are detailed below; |
|
|
|
|
|
|
2025 |
| £ |
|
Balance as at 01/04/24 (due to the director) |
|
3,908 |
|
Net salary credited |
|
23,192 |
|
Dividend credited |
|
50,000 |
|
Mileage claim credited |
1,755 |
|
Use of home |
780 |
|
Repayment of loans |
|
141,000 |
|
Loans to daughter |
|
(20,212) |
|
Loans to director |
|
(155,600) |
|
Director's personal expenses met by company funds |
|
(104,107) |
|
Balance as at 31/03/25 (due by the director) |
|
(59,284) |
|
| 7 |
Other information |
|
|
Gelli Pharmacy Limited is a private company limited by shares and incorporated in Wales. Its registered office is: |
|
66 Whitchurch Road |
|
Maindy |
|
Cardiff |
|
South Wales |
|
CF14 3LX |